LATEST ALERTS
Cannabinoids
Senate passes hemp law amendments bill…
10th February 2023 - Alerts | North America, United States, Virginia |
Amendments to cannabis regulations are approved…
10th February 2023 - Alerts | New Jersey, North America, United States |
CBD markets database Q4 2022
8th February 2023 - Market data |
This comprehensive CBD markets database is a one-stop source for market sizes, forecasts and product-specific analyses, covering Austria, Canada, France, Germany, Greece, Ireland, Italy, Japan, Netherlands, Spain, Switzerland, the UK and the US
Government considering ACMD advice on CBD products…
6th February 2023 - Alerts | Europe, United Kingdom |
Mexican CBD retailer sets itself up as market leader ahead of regulations
3rd February 2023 - News analysis |
Mexican CBD shop Paradise says it has placed itself in prime position for the creation of a legal recreational cannabis market in the country
Greece: CBD and cannabis regulation, February 2023
3rd February 2023 - Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place for CBD and other cannabinoids, hemp and cannabis
EFSA denies waiting to follow US FDA’s lead on CBD safety in novel foods
1st February 2023 - News analysis |
The European Food Safety Authority denies it is waiting research results on the safety of CBD by the US Food and Drug Administration before it lets validated candidates complete the novel food application process
São Paulo state policy to OK free CBD-based products with prescription…
1st February 2023 - Alerts | Brazil, South America |
22nd Century Group acquires a UK cannabinoid distributor for $650K
30th January 2023 - News analysis |
US company 22nd Century Group has acquired privately held UK cannabinoid distributor RX Pharmatech for an up-front payment of $650,000 in cash and stock
US FDA issues guidance for development of cannabis-based medical drugs
27th January 2023 - News analysis |
The US Food and Drug Administration (FDA) has issued a final guidance document for the development of medical drugs containing cannabis
Crack down on incorrect cannabis product labelling…
27th January 2023 - Alerts | Canada, North America |
Minister confirms no assessment made of CBD report…
27th January 2023 - Alerts | Europe, United Kingdom |
US FDA says lack of evidence for dietary-supplement pathway to CBD regulation
26th January 2023 - News analysis |
The US Food and Drug Administration (FDA) has rejected a regulatory pathway that would allow CBD products to be treated as food additives or dietary supplements
FDA to work with Congress on new regulatory pathway for CBD…
26th January 2023 - Alerts | North America, United States |
Rules adopted for low-THC medical cannabis oil programme…
26th January 2023 - Alerts | Georgia US, North America, United States |
Developing countries could get economic boost from industrial hemp, says UN
25th January 2023 - News analysis |
Government and industry representatives from around the world met in Geneva last week to hear about the “significant economic opportunities” offered by industrial hemp and the need for greater clarity on its legal status
Senate passes bill that revises hemp product definition…
25th January 2023 - Alerts | North America, North Dakota, United States |
FDA publishes guidance for cannabis and clinical research…
25th January 2023 - Alerts | North America, United States |
CBD and THC to banned on hempseed labels…
25th January 2023 - Alerts | Asia, South Korea |
Japan CBD insights dashboard, Q3 2022
24th January 2023 - Market data |
This interactive dashboard provides a detailed look at the current CBD market in Japan, including information about product formats, pricing and brands
Netherlands CBD insights dashboard, Q3 2022
23rd January 2023 - Market data |
This interactive dashboard provides a detailed look at the current CBD market in the Netherlands, including information about product formats, pricing and brands
US CBD insights dashboard, Q3 2022
23rd January 2023 - Market data |
This interactive dashboard provides a detailed look at the current CBD market in the United States, including information about product formats, pricing and brands
France CBD insights dashboard, Q3 2022
19th January 2023 - Market data |
This interactive dashboard provides a detailed look at the current CBD market in France, including information about product formats, pricing and brands
Russia: CBD and cannabis regulation, January 2023
19th January 2023 - Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place in Russia for hemp, CBD and cannabis, covering all areas of policy
UK CBD insights dashboard, Q3 2022
17th January 2023 - Market data |
This interactive dashboard provides a detailed look at the current CBD market in the UK, including information about product formats, pricing and brands
Denmark: CBD and cannabis regulation, January 2023
17th January 2023 - Regulatory reports |
This report offers a comprehensive overview of the current regulatory framework in place in Denmark for hemp, CBD and other cannabinoids, as well as medical and recreational cannabis
French court overturns government ban on hemp flowers, shops can sell again
16th January 2023 - News analysis |
The French Council of State has definitively ruled that a 2021 government decree banning hemp flowers is illegal and must be annulled. This major decision fully authorises French shops to sell CBD products, including flowers, without any fear of punishment for working outside the law
Belgium: CBD and cannabis regulation, January 2023
16th January 2023 - Regulatory reports |
This report provides a detailed overview of Belgium’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes
Investigation over FDA inaction over CBD and hemp…
13th January 2023 - Alerts | North America, United States |
FDA expected to issue recommendation ‘soon’ on CBD regulation in the US
13th January 2023 - News analysis |
The US Food and Drug Administration (FDA) may soon issue recommendations for a long-awaited regulation of CBD products in the country
Germany CBD insights dashboard, Q3 2022
13th January 2023 - Market data |
This interactive dashboard provides a detailed look at the current CBD market in Germany, including information about product formats, pricing and brands
Much-needed research into SCRAs’ huge medical potential faces high barriers
12th January 2023 - Blogs |
The recreational reputation of synthetic cannabinoids – synthetic cannabinoid receptor agonists (SCRAs) – precedes them, leading to restrictions on use and even research
Google changes policy to allow advertising of certain CBD products…
9th January 2023 - Alerts | North America, United States |
FDA to make regulation recommendations for CBD…
9th January 2023 - Alerts | North America, United States |
Japan cannabinoid conference-goers look forward to future with legal reforms
9th January 2023 - News analysis |
There are high hopes for the Japanese cannabinoid sector ahead of the legal reforms expected later this year, according to speakers at the CBD Journey Vol. 4 and CannaCon 2022 event and conference held at the end of 2022
Monaco: CBD and cannabis regulation, January 2023
9th January 2023 - Regulatory reports |
This report provides a detailed summary of the current regulations in place for hemp, cannabis and CBD in Monaco, covering all areas from cultivation and processing to extracts and finished products
Australia: CBD and cannabis regulation, January 2023
4th January 2023 - Regulatory reports |
This report provides a detailed overview of Australia’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes
